Literature DB >> 9755272

Comparison of fentanyl/midazolam with ketamine/midazolam for pediatric orthopedic emergencies.

R M Kennedy1, F L Porter, J P Miller, D M Jaffe.   

Abstract

OBJECTIVE: Emergency management of pediatric fractures and dislocations requires effective analgesia, yet children's pain is often undertreated. We compared the safety and efficacy of fentanyl- versus ketamine- based protocols.
METHODOLOGY: Patients 5 to 15 years of age needing emergency fracture or joint reduction (FR) were randomized to receive intravenous midazolam plus either fentanyl (F/M) or ketamine (K/M). Measures of efficacy were observational distress scores and self- and parental-report. Measures of safety were frequency of abnormalities in and need for support of cardiopulmonary function and other adverse effects.
RESULTS: During FR, K/M subjects (n = 130) had lower distress scores and parental ratings of pain and anxiety than did F/M subjects (n = 130). Although both regimens equally facilitated reductions, deep sedation, and procedural amnesia, orthopedists favored K/M. Recovery was 14 minutes longer for K/M. Fewer K/M subjects had hypoxia (6% vs 25%), needed breathing cues (1% vs 12%), or required oxygen (10% vs 20%) than did F/M subjects. Two K/M subjects required assisted ventilation briefly. More K/M subjects vomited. Adverse emergence reactions were rare but equivalent between regimens.
CONCLUSIONS: During emergency pediatric orthopedic procedures, K/M is more effective than F/M for pain and anxiety relief. Respiratory complications occurred less frequently with K/M, but respiratory support may be needed with either regimen. Both regimens facilitate reduction, produce amnesia, and rarely cause emergence delirium. Vomiting is more frequent and recovery more prolonged with K/M.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755272     DOI: 10.1542/peds.102.4.956

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

Review 1.  Options and Considerations for Procedural Sedation in Pediatric Imaging.

Authors:  John W Berkenbosch
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

Review 2.  A review of the use of propofol for procedural sedation in the emergency department.

Authors:  L Symington; S Thakore
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

Review 3.  The Expanding Role of Ketamine in the Emergency Department.

Authors:  Sophia Sheikh; Phyllis Hendry
Journal:  Drugs       Date:  2018-05       Impact factor: 9.546

4.  Comparison of ketamine and ketofol for deep sedation and analgesia in children undergoing laser procedure.

Authors:  Marija Stevic; Nina Ristic; Ivana Budic; Nebojsa Ladjevic; Branislav Trifunovic; Ivan Rakic; Marko Majstorovic; Ivana Burazor; Dusica Simic
Journal:  Lasers Med Sci       Date:  2017-07-12       Impact factor: 3.161

Review 5.  Anxiolytic premedication for children.

Authors:  S Heikal; G Stuart
Journal:  BJA Educ       Date:  2020-04-21

Review 6.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

Review 7.  Pharmacological management of pain and anxiety during emergency procedures in children.

Authors:  R M Kennedy; J D Luhmann
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

8.  Pediatric procedural sedation and analgesia.

Authors:  James R Meredith; Kelly P O'Keefe; Sagar Galwankar
Journal:  J Emerg Trauma Shock       Date:  2008-07

9.  Pediatric sedation: a global challenge.

Authors:  David Gozal; Keira P Mason
Journal:  Int J Pediatr       Date:  2010-10-19

Review 10.  Ketamine for paediatric sedation/analgesia in the emergency department.

Authors:  M C Howes
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.